journal article·2023-01

Transcranial deep-tissue phototherapy for Alzheimer's disease using low-dose X-ray-activated long-afterglow scintillators

Mengmeng Ma, Jing Wang, Hao Jiang, Qiushui Chen, Yi Xiao, Huanghao Yang, Li Lin

Acta Biomaterialia· Volume 155
Publisher page

Abstract

Non-invasive phototherapy has been emerging as an ambitious tactic for suppression of amyloid-β (Aβ) self-assembly against Alzheimer's disease (AD). However, it remains a daunting challenge to develop efficient photosensitizers for Aβ oxygenation that are activatable in a deep brain tissue through the scalp and skull, while reducing side effects on normal tissues. Here, we report an Aβ targeted, low-dose X-ray-excitable long-afterglow scintillator (ScNPs@RB/Ab) for efficient deep-brain phototherapy. We demonstrate that the as-synthesized ScNPs@RB/Ab is capable of converting X-rays into visible light to activate the photosensitizers of rose bengal (RB) for Aβ oxygenation through the scalp and skull. We show that the ScNPs@RB/Ab persistently emitting visible luminescence can substantially minimize the risk of excessive X-ray exposure dosage. Importantly, peptide KLVFFAED-functionalized ScNPs@RB/Ab shows a blood-brain barrier permeability. In vivo experimental results validated that ScNPs@RB/Ab alleviated Aβ burden and slowed cognitive decline in triple-transgenic AD model mice at extremely low X-ray doses without side effects. Our study paves a new pathway to develop high-efficiency transcranial AD phototherapy. STATEMENT OF SIGNIFICANCE: Non-invasive phototherapy has been emerging as an ambitious tactic for suppression of amyloid-β (Aβ) self-assembly against Alzheimer's disease (AD). However, it remains a daunting challenge to develop efficient photosensitizers for Aβ oxygenation that are activatable in a deep brain tissue through the scalp and skull, while reducing side effects on normal tissues. Herein, we report an Aβ targeted, low-dose X-ray-excitable long-afterglow scintillators (ScNPs@RB/Ab) for efficient deep-brain phototherapy. In vivo experimental results validated that ScNPs@RB/Ab alleviated Aβ burden and slowed cognitive decline in triple-transgenic AD model mice at extremely low X-ray doses without side effects.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Optical Imaging and Spectroscopy Techniques · bioluminescence and chemiluminescence research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. 2022 Alzheimer's disease facts and figures. Alzheimers Dement.. 18 (2022) 700-789.10.1002/alz.12638 ↗
2. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics10.1126/science.1072994 ↗
3. Alzheimer's disease10.1038/nrdp.2015.56 ↗
4. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases10.1038/ncb1104-1054 ↗
5. Mimosine functionalized gold nanoparticles (Mimo-AuNPs) suppress β-amyloid aggregation and neuronal toxicity
6. Photosensitizing materials and platforms for light-triggered modulation of Alzheimer's β-amyloid self-assembly10.1016/j.biomaterials.2018.10.043 ↗
7. Attenuation of the aggregation and neurotoxicity of amyloid-beta peptides by catalytic photooxygenation10.1002/anie.201308001 ↗
8. Photoexcited porphyrins as a strong suppressor of β-amyloid aggregation and synaptic toxicity10.1002/anie.201504310 ↗
9. Switchable photooxygenation catalysts that sense higher-order amyloid structures10.1038/nchem.2550 ↗
10. Photo-induced inhibition of Alzheimer's β-amyloid aggregation in vitro by rose bengal10.1016/j.biomaterials.2014.10.058 ↗
11. Photo-inhibition of Aβ fibrillation mediated by a newly designed fluorinated oxadiazole10.1039/C4RA13556C ↗
12. Catalytic photooxygenation degrades brain Aβ in vivo10.1126/sciadv.abc9750 ↗
13. Porphyrinic metal-organic framework PCN-224 nanoparticles for near-infrared-induced attenuation of aggregation and neurotoxicity of Alzheimer's amyloid-β peptide10.1021/acsami.8b15452 ↗
14. Light-induced chiral iron copper selenide nanoparticles prevent β-amyloidopathy in vivo10.1002/anie.202002028 ↗
15. Target-driven supramolecular self-assembly for selective amyloid-beta photooxygenation against Alzheimer's disease10.1039/D0SC04984K ↗
16. Photo-oxygenation by a biocompatible catalyst reduces amyloid-β levels in Alzheimer's disease mice10.1093/brain/awab058 ↗
17. Photomodulating carbon dots for spatiotemporal suppression of Alzheimer's β-amyloid aggregation10.1021/acsnano.0c06078 ↗
18. Rattle-structured upconversion nanoparticles for near-IR-induced suppression of Alzheimer's β-amyloid aggregation10.1002/smll.201603139 ↗
19. Near-infrared photoactivatable oxygenation catalysts of amyloid peptide10.1016/j.chempr.2018.02.008 ↗
20. NIR-II Hydrogen-Bonded Organic Frameworks (HOFs) used for target specific amyloid-β photooxygenation in an Alzheimer's disease model
21. Near-infrared activated black phosphorus as a nontoxic photo-oxidant for Alzheimer's amyloid-β peptide
22. Near-infrared-active copper bismuth oxide electrodes for targeted dissociation of Alzheimer's β-amyloid aggregates10.1021/acsami.0c02349 ↗
23. Measurement of the penetration depths of red and near infrared light in human “ex vivo” tissues10.1016/S1011-1344(00)00082-8 ↗
24. In vivo three-photon microscopy of subcortical structures within an intact mouse brain10.1038/nphoton.2012.336 ↗
25. Bioimaging: second window for in vivo imaging10.1038/nnano.2009.326 ↗
26. Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics10.1126/science.aaq1144 ↗
27. On a new kind of rays10.1126/science.3.59.227 ↗
28. Nanoscale metal-organic layers for deeply penetrating x-ray-induced photodynamic therapy10.1002/anie.201704828 ↗
29. Wireless optogenetic modulation of cortical neurons enabled by radioluminescent nanoparticles10.1021/acsnano.0c10436 ↗
30. In vivo X-ray triggered catalysis of H2 generation for cancer synergistic gas radiotherapy10.1002/anie.202100002 ↗
31. Breaking the depth dependence by nanotechnology-enhanced X-ray-excited deep cancer theranostics10.1002/adma.201806381 ↗
32. Enhancing light and X-ray charging in persistent luminescence nanocrystals for orthogonal afterglow anti-counterfeiting10.1002/adfm.202009920 ↗
33. Low dose soft X-ray remotely triggered lanthanide nanovaccine for deep tissue CO gas release and activation of systemic anti-tumor immunoresponse
34. All-inorganic perovskite nanocrystal scintillators10.1038/s41586-018-0451-1 ↗
35. Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy10.1038/s41551-018-0203-4 ↗
36. X-ray-activated nanosystems for theranostic applications10.1039/C8CS00921J ↗
37. Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination10.1126/sciadv.abb5223 ↗
38. Synergistic assembly of heavy metal clusters and luminescent organic bridging ligands in metal-organic frameworks for highly efficient X-ray scintillation10.1021/ja500671h ↗
39. Repeatable deep-tissue activation of persistent luminescent nanoparticles by soft X-ray for high sensitivity long-term in vivo bioimaging10.1039/C6NR09553D ↗
40. X-ray-activated persistent luminescence nanomaterials for NIR-II imaging10.1038/s41565-021-00922-3 ↗
41. Biomimetic dendrimer-peptide conjugates for early multi-target therapy of Alzheimer's disease by inflammatory microenvironment modulation
42. High-resolution X-ray luminescence extension imaging10.1038/s41586-021-03251-6 ↗
43. Lanthanide-activated nanoparticles: a toolbox for bioimaging, therapeutics, and neuromodulation10.1021/acs.accounts.0c00513 ↗
44. Designing next generation of persistent luminescence: recent advances in uniform persistent luminescence nanoparticles
45. Three-dimensional colloidal controlled growth of core-shell heterostructured persistent luminescence nanocrystals10.1021/acs.nanolett.0c04940 ↗
46. Lanthanide-doped core-shell-shell nanocomposite for dual photodynamic therapy and luminescence imaging by a single X-ray excitation source10.1021/acsami.8b00015 ↗
47. Bright sub-20-nm cathodoluminescent nanoprobes for electron microscopy10.1038/s41565-019-0395-0 ↗
48. Ultra-high FRET efficiency NaGdF4: Tb3+-Rose Bengal biocompatible nanocomposite for X-ray excited photodynamic therapy application10.1016/j.biomaterials.2018.09.001 ↗
49. Nanocomposites inhibit the formation, mitigate the neuroto.xicity, and facilitate the removal of β-amyloid aggregates in Alzheimer's disease mice10.1021/acs.nanolett.8b03644 ↗
50. A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis10.1038/s41467-018-07197-8 ↗
51. Near-infrared target enhanced peripheral clearance of amyloid-β in Alzheimer's disease model10.1016/j.biomaterials.2021.121065 ↗
52. Thioflavin T-amyloid hybrid nanostructure for biocatalytic photosynthesis10.1002/smll.201801396 ↗
53. Neurodegenerative diseases and effective drug delivery: a review of challenges and novel therapeutics10.1016/j.jconrel.2020.11.021 ↗
54. Penetrating the blood-brain barrier: promise of novel nanoplatforms and delivery vehicles10.1021/acsnano.5b05341 ↗
55. Baicalein attenuates impaired hippocampal neurogenesis and the neurocognitive deficits induced by γ-ray radiation10.1111/j.1476-5381.2012.02142.x ↗
56. Low-dose x-ray activation of W(VI)-doped persistent luminescence nanoparticles for deep-tissue photodynamic therapy10.1002/adfm.201707496 ↗